Latest Leadership News

SEEK Limited projects strong FY25 revenue and earnings in the top half of guidance, driven by AI-powered product innovation and expanded market reach across Asia-Pacific.

Plenti Group Limited has reported a remarkable turnaround with a $24.8 million profit for the year ended March 2025, reversing a loss from the previous year. The fintech lender also announced its upcoming Annual General Meeting and director nomination deadlines.

LTR Pharma has appointed Associate Professor Darren Katz, a leading urologist and erectile dysfunction expert, to its Scientific Advisory Board, aiming to fast-track the development and commercialization of its innovative nasal spray treatments SPONTAN and ROXUS.

Catapult Group International Ltd reported a milestone FY25 with ACV exceeding US$100 million, driven by strong SaaS growth and record profitability. The company’s innovative product launches and improved cost efficiencies underpin a confident outlook for FY26.

Renergen Limited is poised to be acquired by US-based ASP Isotopes Inc. in a deal that aims to create a powerhouse in critical helium and isotope supply chains. The merger promises expanded market access and strategic value across key industries.

James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.

Brisbane Broncos Limited revealed solid financial results and operational growth for 2024 at their 2025 Annual General Meeting, highlighting record membership and commercial gains alongside strategic investments.

Despite a tough 2024 NRL season for the men's team, Brisbane Broncos delivered record memberships, increased attendance, and a solid financial performance with a $5.7 million profit.

Kogan.com Ltd reports robust sales and profit growth for the first four months of 2025, powered by strong marketing investment, while its subsidiary Mighty Ape faces technical setbacks but shows early signs of recovery.

Sayona Mining reports solid FY25 operational gains and outlines strategic merger progress with Piedmont Lithium, positioning itself as a leading North American lithium producer amid a recovering market.

Worley Limited has reaffirmed its FY25 financial outlook, targeting low double-digit EBITA growth and margins between 8-8.5%, supported by a robust $9.4 billion bookings pipeline and a strategic operational reorganisation.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.